Source: Annual Congress 2010 - A new understanding of childhood wheeze phenotypes



Rating:

Share or cite this content

Citations should be made in the following way:
A. Schultz (Perth, Australia). Impact of phenotyping upon treatment choices in childhood. Annual Congress 2010 - A new understanding of childhood wheeze phenotypes

Member's Comments

No comment yet.

Related content which might interest you: Impact of phenotyping in childhood upon treatment choices in adult life Source: Annual Congress 2010 - A new understanding of childhood wheeze phenotypes Year: 2010 Evaluation and management of difficult asthma Source: Annual Congress 2010 - PG3 Core Curriculum Postgraduate Course: Asthma: from bench to bedside Year: 2010 Multidimensional approaches to asthma: the need to look beyond drug treatments Source: Annual Congress 2010 - Breathing therapies for asthma Year: 2010 Assessment and treatment of comorbidity: what efforts pay off? Source: Annual Congress 2011 - The non-parmacological management of COPD exacerbations Year: 2011 Lessons learned from the epidemiology and natural history of asthma: Outcomes and treatment regimens (TENOR) Source: Annual Congress 2011 - Dilemmas and progress in understanding childhood asthma Year: 2011 Extending the use of timepoint diagnosis of occupational asthma Source: Annual Congress 2010 - Occupational asthma: aetiology, persistence and quality of life Year: 2010 COPD: An outcome of childhood asthma? Source: Annual Congress 2010 - Functional assessment of paediatric lung disease Year: 2010 Stepping up the controller medication in asthma patients: Impact of various treatment options on costs Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care Year: 2011 Initiation of controller medication in newly diagnosed asthma patients: Impact on economic resource utilization Source: Annual Congress 2011 - New insights in the incidence, variation and risk factors of asthma Year: 2011 Monitoring asthma in childhood: what tools are available and documented? Source: Annual Congress 2011 - The digital highway: innovative monitoring of asthma Year: 2011 How to optimise the efficacy of pharmacological treatments? Source: Annual Congress 2011 - New advances in smoking cessation Year: 2011 Phenotyping of asthma Source: Annual Congress 2010 - PG3 Core Curriculum Postgraduate Course: Asthma: from bench to bedside Year: 2010 Compliance with guidelines for pharmacological treatment of COPD: Real-life analyses Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010 Year: 2010 Improving adherence to asthma treatment: motivational interviewing Source: Annual Congress 2011 - The digital highway: innovative monitoring of asthma Year: 2011 Comparison of different methods for COPD diagnosis in the primary care setting Source: Annual Congress 2010 - Diagnostic and therapeutic strategies in primary care Year: 2010 Late-breaking abstract: Long-term efficacy of intensive behavior interventions and free medications for smoking cessation in Brazil Source: Annual Congress 2011 - Smoking cessation science Year: 2011 Clinical decision making: when to start long-term NIV following acute exacerbation Source: Annual Congress 2011 - PG2 Noninvasive ventilation (NIV) for stable hypercapnic COPD: recent advances and practical considerations Year: 2011 Early life exposure to locally-generated PM10 and lung function measurements at school-age Source: Annual Congress 2011 - Early wheezing conditions in childhood Year: 2011